Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 04 April, 2012 and appeared in  DietType 2 DiabetesIssue 620

High-fat Diet Raises Risk for Diabetes Complications

High-fat meals increase levels of blood toxins that can cause complications in type 2 diabetes patients.... 

Advertisement

All people experience higher levels of endotoxins, which can lead to heart disease, after eating a meal high in saturated fat. But a study presented at the Society for Endocrinology's annual meeting in Harrogate, Yorkshire, last week, shows these levels peak at more than twice as high in people with type 2 diabetes.

Researchers warned that patients with type 2 diabetes should be wary of high fat, low carbohydrate diets that are promoted for weight loss.

Type 2 diabetics have raised background levels of endotoxin, bacterial fragments which enter the bloodstream from the gut and can cause inflammation and heart disease.

In the study, researchers led by Dr. Alison Harte, research fellow at the University of Warwick, compared the effects of high-fat diet in 54 people. Fifteen were obese, 12 had impaired glucose tolerance, 18 had type 2 diabetes and 9 were non-obese controls.

Researchers monitored blood endotoxin levels for four hours, comparing baseline and post-prandial levels. Although average levels of endotoxin increased for all participants, type 2 patients rose from 5.3 to 14.2EU/ml after four hours. This compared to a rise from 5.1 to 7.7EU/ml among the obese group.

Dr. Harte said: "High fat, low carbohydrate diets are often promoted to patients with type 2 diabetes as they have been suggested to aid weight loss and control blood sugar, but if confirmed in larger studies our data show that being healthy is not just about losing weight, as these particular diets could increase inflammation in some patients and with it the risk of heart disease."

Presented at the Society for Endocrinology's annual meeting in Harrogate, Yorkshire, March 2012

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 04 April, 2012 and appeared in  DietType 2 DiabetesIssue 620

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control
Search Articles On Diabetes In Control